68Ga-NOTA-MAL-Cys39-exendin-4

N/A

Report date: 2025/11/20 16:00:56

Base Information

Drug Name68Ga-NOTA-MAL-Cys39-exendin-4

Drug Alias NameN/A

ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68Ga +[5]

Mechanisms of ActionGlucagon-like peptide 1 receptor agonists

TargetsGlucagon-like peptide 1 receptor

Therapy Area/IndicationsInsulinoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaPending

Originator CompaniesNanjing First Hospital, Nanjing Medical University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNanjing First Hospital, Nanjing Medical University

Active IndicationsN/A

Inactive IndicationsInsulinoma

Other Information

ATC CodeN/A